Examples of antibodies serving as surrogate markers of sarcoma-specific genetic aberrations, e.g., fusions, amplifications, and point mutations, include SS18-SSX or SSX, TFE3, SMARCB1, BCOR, MDM2, DDIT3, and PAX3 [72–74]. Here, MDM2 is linked to sarcoma.